Related Experiment Video

Updated: Jul 25, 2026

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
08:50

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

Published on: April 9, 2018

Secretion of phospholipase A2 induced by interactions of human platelets with monocytes

S Sipka1, T Farkas, P Gergely

  • 1Third Department of Internal Medicine, University Medical School, Debrecen, Hungary.

Annals of Hematology
|December 1, 1994
PubMed

Insights

Human mononuclear cells and platelets interact to release phospholipase A2 (PLA2). This interaction is key for producing and purifying this enzyme, suggesting a role in peripheral blood PLA2 release.

Area of Science:

  • Immunology
  • Biochemistry
  • Cell Biology

Background:

  • Phospholipase A2 (PLA2) is an enzyme implicated in various biological processes.
  • Understanding the cellular sources and regulation of secretable PLA2 is crucial.

Purpose of the Study:

  • To investigate the production and purification of human secretable PLA2.
  • To explore the role of human mononuclear cells and platelets in PLA2 release.

Main Methods:

  • Culturing human mononuclear cells (monocytes and lymphocytes) with platelets.
  • Measuring PLA2 activity in cell-free supernatants.
  • Purifying calcium-dependent PLA2 using biochemical methods.
  • Observing cell-cell interactions via electron microscopy.

Main Results:

  • PLA2 activity was detected in supernatants from mononuclear cell-platelet co-cultures.
  • A 14 kD calcium-dependent PLA2 was purified.
  • PLA2 levels correlated positively with monocyte and platelet numbers.
  • Direct monocyte-platelet interactions were visualized.

Conclusions:

  • Co-culturing mononuclear cells with platelets is an effective method for producing and purifying human secretable PLA2.
  • Monocyte-platelet interactions likely play a significant role in the release of secretable PLA2 in peripheral blood.

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA210:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...